Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05343559 · ClinicalTrials.gov registry record
First Impressions and Attractiveness Levels of Smiling Individuals With and Without a Mask
A clinical trial, sponsored by DeNova Research.
- Completed
- Registry status
- 808
- Enrollment target
NCT05343559: Completed study, sponsored by DeNova Research.
NCT05343559 is a clinical trial that has completed, run by DeNova Research. The registered enrollment target is 808 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05343559 has completed, sponsored by DeNova Research.
- COMPLETED
- Registry status
- 808 participants
- Enrollment target
Study Summary
Evaluation on the effects of smiling on first impressions and attractiveness with and without wearing a facial surgical mask.
Primary Outcome
First impression questionnaire (FIQ)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 808 participants |
| Start Date | 2022-03-04 |
| Est. Completion | 2022-04-01 |
What the finished NCT05343559 record still lists
NCT05343559 is an observational study that tracks outcomes without assigning an intervention. The registered 808 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05343559 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05343559 about?
NCT05343559 is a clinical study titled "First Impressions and Attractiveness Levels of Smiling Individuals With and Without a Mask". Evaluation on the effects of smiling on first impressions and attractiveness with and without wearing a facial surgical mask.
What is the current status of trial NCT05343559?
This trial is currently completed. The enrollment target is 808 participants. The study started on 2022-03-04. Estimated completion is 2022-04-01.
Who is sponsoring clinical trial NCT05343559?
This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI